Skip to main content

Advertisement

Log in

Mastectomy vs Breast-Conserving Surgery: An Old Dilemma Comes Again for Early Breast Cancer

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ziogas D, Roukos DH. Genetics and personal genomics for personalized breast cancer surgery: progress and systems biology. Ann Surg. 2009;249:1067–8.

    Article  Google Scholar 

  2. Roukos DH. Radiation therapy for breast cancer. N Engl J Med. 2009;360:1362; author reply 1363.

    Google Scholar 

  3. McGuire, Santillan AA, Kaur P, Meade T, Parbhoo J, Mathias M, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16:2682–90.

    Article  PubMed  Google Scholar 

  4. Roukos DH. Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and challenges in research and clinical practice. Ann Surg Oncol. 2009;16:1771–82.

    Article  PubMed  Google Scholar 

  5. Roukos DH. Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine. Expert Rev Mol Diagn. 2009;9:217–21.

    Article  PubMed  Google Scholar 

  6. Roukos DH. Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn. 2010;10(3):247–50.

    Article  PubMed  Google Scholar 

  7. Roukos DH. Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancer. J Clin Oncol. 2010. doi:10.1200/JCO.2009.27.7061 [Epub ahead of print].

  8. Roukos DH. Systems medicine: a real approach for future personalized oncology? Pharmacogenomics 2010;11(3):283–7.

    Article  PubMed  Google Scholar 

  9. Roukos DH, Ziogas D. From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther. 2010;10(2):123–8.

    Article  CAS  PubMed  Google Scholar 

  10. Roukos DH. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn. 2010;10(1):33–48.

    Article  CAS  PubMed  Google Scholar 

  11. Roukos DH. Isolated tumor cells in breast cancer. N Engl J Med. 2009;361:1994–5.

    Article  CAS  PubMed  Google Scholar 

  12. Roukos DH, Tzakos A, Zografos G. Current concerns and challenges towards tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther. 2009;9(10):1413–6.

    Article  PubMed  Google Scholar 

  13. Roukos DH. Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance. Ann Surg Oncol. 2010;17:14–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Ziogas MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harissis, H.V., Ziogas, D. & Baltogiannis, G. Mastectomy vs Breast-Conserving Surgery: An Old Dilemma Comes Again for Early Breast Cancer. Ann Surg Oncol 17, 1966–1967 (2010). https://doi.org/10.1245/s10434-010-1103-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1103-3

Keywords

Navigation